14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 AXSM stock ended at $74.80. This is 0.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.64% from a day low at $74.36 to a day high of $76.32.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Dec 13, 2021 $33.32 $34.16 $31.76 $32.55 530 963
Dec 10, 2021 $34.25 $34.87 $32.94 $33.15 492 593
Dec 09, 2021 $34.56 $35.80 $34.06 $34.10 346 337
Dec 08, 2021 $34.36 $35.56 $33.30 $35.13 325 076
Dec 07, 2021 $33.41 $35.26 $33.39 $34.18 417 695
Dec 06, 2021 $31.76 $33.25 $30.50 $32.91 680 048
Dec 03, 2021 $33.35 $33.39 $31.49 $32.24 480 551
Dec 02, 2021 $33.12 $33.63 $32.08 $33.35 463 764
Dec 01, 2021 $34.96 $35.62 $32.62 $33.16 669 357
Nov 30, 2021 $33.92 $34.64 $32.62 $34.54 685 314
Nov 29, 2021 $37.24 $37.40 $34.19 $34.34 814 214
Nov 26, 2021 $37.00 $38.10 $36.42 $36.92 314 279
Nov 24, 2021 $36.46 $38.44 $35.44 $37.93 412 714
Nov 23, 2021 $37.25 $37.50 $35.61 $36.59 515 599
Nov 22, 2021 $37.48 $37.86 $34.82 $36.84 840 324
Nov 19, 2021 $36.29 $39.00 $35.17 $35.80 1 025 756
Nov 18, 2021 $34.50 $35.92 $33.21 $35.59 779 642
Nov 17, 2021 $35.28 $36.23 $34.20 $34.55 643 668
Nov 16, 2021 $38.26 $38.26 $35.13 $35.50 953 705
Nov 15, 2021 $39.25 $39.36 $36.81 $38.48 650 689
Nov 12, 2021 $39.75 $39.83 $38.28 $39.26 336 996
Nov 11, 2021 $38.23 $40.00 $37.65 $39.52 397 810
Nov 10, 2021 $40.21 $40.60 $37.51 $38.17 746 469
Nov 09, 2021 $42.64 $43.97 $39.87 $40.77 775 346
Nov 08, 2021 $39.93 $44.83 $38.07 $43.36 1 806 536
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT